Sugi Predict

Sugi Predict / Compounds / SCHEMBL10026720

SCHEMBL10026720

SCHEMBL10026720

CN(C)C(=O)N1C2CCC1CC(C(NC(=O)OC(C)(C)C)C(=O)O)C2

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 P08172 1/20 0.39
▸ CHRM1 P11229 1/20 0.39
▸ CHRM3 P20309 1/20 0.39
▸ ELANE P08246 1/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ AAK1 Q2M2I8 3/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ MMP13 P45452 1/20 0.34
▸ CTSS P25774 2/20 0.34
▸ CTSK P43235 2/20 0.34
▸ BTK Q06187 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA7 P43166 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ GFER P55789 1/20 0.32
▸ PREP P48147 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL895624 1.00 CHRM2 (0.39) CHRM2CHRM1CHRM3ELANEL3MBTL1
SCHEMBL894936 0.89 CHRM2 (0.38) CHRM2CHRM1CHRM3ELANEL3MBTL1
SCHEMBL10026719 0.89 CHRM2 (0.38) CHRM2CHRM1CHRM3ELANEL3MBTL1
SCHEMBL3744310 0.86 CHRM2 (0.55) CHRM2CHRM1CHRM3ELANEAAK1
SCHEMBL11965227 0.86 CHRM2 (0.41) CHRM2CHRM1CHRM3ELANEL3MBTL1
SCHEMBL7857233 0.85 CHRM2 (0.36) CHRM2CHRM1CHRM3ELANEL3MBTL1
SCHEMBL11982496 0.82 CHRM2 (0.38) CHRM2CHRM1CHRM3ELANEL3MBTL1
SCHEMBL3751248 0.81 BTK (0.40) CHRM2CHRM1CHRM3ELANEGAA
SCHEMBL7859357 0.81 ELANE (0.34) CHRM2CHRM1CHRM3ELANEAAK1
SCHEMBL895334 0.81 ELANE (0.36) CHRM2CHRM1CHRM3ELANEAAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8748457-B2 2-amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent DPP-IV inhibitors LUPIN LIMITED (IN) 2014-06-10 — — US disclosed
US-8748457-B2 2-amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent DPP-IV inhibitors LUPIN LIMITED (IN) 2014-06-10 — — US disclosed
US-20120082635-A1 2-AMINO-2- [8-(DIMETHYL CARBAMOYL)- 8-AZA- BICYCLO [3.2.1] OCT-3-YL]-EXO- ETHANOYL DERIVATIVES AS POTENT DPP-IV INHIBITORS LUPIN LIMITED (IN) 2012-04-05 — — US disclosed
US-20120082635-A1 2-AMINO-2- [8-(DIMETHYL CARBAMOYL)- 8-AZA- BICYCLO [3.2.1] OCT-3-YL]-EXO- ETHANOYL DERIVATIVES AS POTENT DPP-IV INHIBITORS LUPIN LIMITED (IN) 2012-04-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120082635-A1 2-AMINO-2- [8-(DIMETHYL CARBAMOYL)- 8-AZA- BICYCLO [3.2.1] OCT-3-YL]-EXO- ETHANOYL DERIVATIVES AS POTENT DPP-IV INHIBITORS DPP7, DPP4, DPP8 CHRM2 1729/4885CHRM1 2396/4885CHRM3 2324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.